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TB/HIV coinfection is a serious public health issue in Brazil, and patients with coinfection
have difficulty adhering to treatments. Directly observed treatment (DOT) has been recom-
mended by the World Health Organization, considering the vulnerability of those affected.
The purpose is to investigate the occurrence of DOT and associated factors compared to
conventional treatment in Porto Alegre, Brazil.
Methods
A retrospective cohort study was carried out with all patients with coinfection from 2009 to
2013 in the city of Porto Alegre, Brazil, the state capital with the highest rate of coinfection in
Brazil. The data came from national health information systems. The dependent variable
was the performance of DOT. Bivariate and multivariable models were used to determine
factors associated with DOT. The percentage of cure and death was verified in a period of
two years, comparing patients who received and did not receive DOT.
Results
2,400 cases of coinfection were reported, with 1,574 males and 826 females and a mean
age of 38 years ± 9.91 years. The occurrence of DOT was 16.9%. In the multivariable analy-
sis, factors independently associated to DOT were the year (with greater chances of being
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received in 2012 and 2013), place of origin, non-white race (OR = 1.29, 95% CI = 1.08–
1.54), cases of relapse (OR = 1.33; 95% CI = 1.03–1.73), readmission after abandonment
(OR = 1.48, 95% CI = 1.20–1.83), transfer (OR = 2.04; 95% CI = 1.40–2.98), acid-fast bacilli
(AFB) test with positive result in first sample (OR = 1.73, 95% CI = 1.24–2.42), alcohol
abuse (OR = 1.39; 95% CI = 1.16–1.67), and mental disorders (OR = 1.83; 95% CI = 1.38–
2.44.) Of the 532 cases of death, occurring in two years, 10.2% were in patients who under-
went DOT and 89.8% in patients who did not undergo DOT (p<0.001). O percentual de
óbitos em pessoas que receberam DOT foi de 13% e o percentual de óbitos para pessoas
que receberam tratamento convencional foi de 24%.
Conclusions
There was an increase in the percentage of DOT over the years in the scenario studied, and
the predictors for DOT were related to social vulnerability. In relation to death within two
years, a lower proportion was found in patients who underwent DOT, suggesting a protec-
tive effect of the strategy.
Introduction
Tuberculosis (TB) and AIDS are considered to be neglected diseases due to their association
with poverty, the vulnerability of individuals and the contribution to health inequalities [1,2].
WHO estimates that worldwide in 2017 there were 920,000 new cases of TB among those
infected with HIV, equivalent to 9.2% of the 10 million new cases of tuberculosis diagnosed in
the same year. Among people living with HIV/AIDS, 0.3 million died of tuberculosis in 2017
[3].
Brazil is the country with the highest number of new cases of tuberculosis in the Americas,
with a total of 91,000 estimated cases in 2017, equivalent to 32% of all estimated cases of the
disease in the Americas [4,5]. As of 2016, 6,501 people with HIV developed tuberculosis [6]. In
Porto Alegre, coinfection cases accounted for 24.1% of new cases of tuberculosis in 2016 [6].
Identification and treatment of TB/HIV coinfection are essential to reduce the number of
cases of morbidity and mortality for both diseases. As for TB treatment in Porto Alegre, only
61.4% of the new cases of the disease in 2015 were cured, and the percentage of treatment
abandonment was 16.3% of the new cases [5].
Non-adherence to drug therapy is the major barrier to treatment success as abandonment
is a factor for the follow-up of disease transmission, with an impact on relapse rates of coinfec-
tion and increasing drug resistance [7–9]. Risk factors for abandonment include being male
between the ages of 30 and 39, being illiterate or not having completed high school, having
family conflicts, not living in the central districts of cities, being a user of licit and/or illicit
drugs, and having previously been treated for TB [10].
Against this background, the challenge of public policies is to guarantee the adherence of
people with coinfection to the treatments. The main strategy of the World Health Organization
to promote adherence is the Directly Observed Therapy Short Course (DOTS), a strategy pro-
posed since 1991 and made up of five components: political commitment, case detection
through sputum smear microscopy; Directly Observed Treatment (DOT); a regular supply of
medicines; and a system of notification and follow-up of cases. In 2015, in order to control TB,
the WHO set targets through the Stop TB Partnership, recommending the implementation of
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DOTS [2]. In Brazil, the need for DOT is assessed by the primary or secondary care health
team and performed by the primary care health team. Conventional treatment for co-infection
cases consists of monthly consultations with primary and secondary care teams, without direct
observation of medication intake. The DOT is directed to the treatment of tuberculosis and
performed by the nursing staff. It consists of the daily observation of medication intake for at
least the first 30 days of treatment and may continue until the end of treatment. [11].
In scenarios with a high proportion of abandonment, treatment failure and frequency of
adverse events in patients with coinfection, it is necessary to intensify strategies to promote
effective treatment [11]. Regarding coinfection, international recommendations emphasize the
reduction of multidrug resistance (MDR) and mortality, with timely diagnosis and DOT as the
main focus [2]. In a Brazilian study that analyzed cases of TB-HIV co-infection reported in the
Brazilian information system (SINAN) between 2001 and 2011, it was seen that DOT gave pro-
tection against TB treatment abandonment and death [12]. In Rio de Janeiro, a 2018 study
identified an association between TB treatment outcome and clinical and sociodemographic
factors. However, this study did not analyze cases of TB / HIV co-infection [13]. In Porto Ale-
gre, a recent study showed that the occurrence of hospitalizations and deaths is high among
people with both HIV and TB [14]. Thus, the aim was to investigate the occurrence of DOT
and associated factors compared to conventional treatment.
Materials and methods
Study design
This is a retrospective cohort study, classified as a dynamic or open cohort [15]. Participants
were included in the study at any time between 2009 and 2013. In this type of cohort, there is
no fixed recruitment period for individuals, and in view of the possibility of recurrence due to
tuberculosis, patients entered the cohort if they were diagnosed and registered in the national
surveillance system. Thus, the study was based on cases of coinfection, and the case definition
corresponds to the entry in the Epidemiological Surveillance System. Considering that the fol-
low-up period was up to two years, closure occurred in 2015 in order to ensure the equal fol-
low-ups of all patients.
Study population
The participants of this study are all patients with a diagnosis of TB/HIV coinfection in the
city of Porto Alegre, aged over 18 years, and registered in the national health surveillance sys-
tem from 2009 to 2013. The sample is expected to correspond to the totality of patients with
coinfection, since TB and HIV are compulsory notification diseases in Brazil and, therefore, all
patients diagnosed should be notified by the national surveillance system. Nevertheless, the
existence of underreporting in this system should be considered, and so SINAN TB cases can
be considered a proxy of TB cases in Brazil.
Study procedures
The dependent variable of the study was the achievement of directly observed treatment. The
sociodemographic variables were: sex (female and male), years of education completed, age
and race (white and not white). From the clinical point of view, we analyzed: entry into the
surveillance system, bacilloscopy examination (positive, negative or not performed), the occur-
rence of other negative factors (alcohol abuse and mental disorders), and status at completion
that were obtained from the national tuberculosis notification data bank (SINAN-TB). The
type of entry was classified into new case (never treated), relapse (patient cured and infected
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once again by tuberculosis), return after default (patient who interrupted the treatment and is
about to resume it) or transfer (patients who had been transferred from another town or city
to the city of Porto Alegre). The new case category was defined as the reference category for
analysis. The variable status at completion refers to what happened after the tuberculosis treat-
ment was monitored by the national surveillance system, that is: cure, default, transference,
death or multiresistance. In this same bank, the occurrence of coinfection was identified.
The DOT Indication variable considered the indication of treatment at the moment of the
notification/diagnosis of the case. The indication of DOT is a clinical judgment made by the
professional who completed the notification form.
For the reliability of the study data, information on the total of coinfected and the number
of deaths were also checked in other national databases. Following the organization of the
study database from the SINAN-TB system [16], all cases of TB whose HIV test was negative
or in progress were checked in the national HIV/AIDS notification system (SINAN-HIV/
AIDS) [16].
Patient follow-up occurred until the closure of the case in the tuberculosis surveillance sys-
tem, which occurred after 12 months of follow-up, with the patient’s classification as cure,
abandonment, death, multidrug-resistant TB, or transfer. For more reliable information on
TB/HIV mortality, all cases of coinfection were subsequently checked in the National Mortal-
ity Information System (SIM) [17], and 3 cases were found not to have been included in the
tuberculosis surveillance system as death within 12 months of follow-up, but whose death had
actually occurred within 12 months due to TB/HIV.
Despite being a study with secondary databases, patient identification was required for veri-
fication in different databases. The patient’s full name, mother’s name and registration number
in the public health system were used as an identification procedure, and it was necessary to
confirm these three data sets to consider that it was the same case in the tuberculosis, HIV/
AIDS, and SIM databases. There were only 2 SINAN cases where the patients were not
reported as having died of tuberculosis and whose full name and mother’s name were identical
in the SIM, but given that the health card number was different, they were not included as
deaths.
In terms of the place of residence, the patients were classified by the District Health Author-
ities (DHA). The DHA are configured as administrative structures for the management of the
local health network and may include more than one health district. There are eight DHA in
Porto Alegre: Centro (CEN), North/Baltazar Axis (NEB), East/Northeast (LENO), Gloria/Cru-
zeiro/Cristal (GCC), South/Center-South (SCS), Partenon/Lomba do Pinheiro (PLP), Rest-
inga/South End (RES), and Northwest/Humaitá/Navegantes/Ilhas (NHNI), some of which
present greater social vulnerability, depending on the population profile [18].
After the classification of the patients by DHA, according to their address, the identification
information of the cases (full name, mother’s name, health card number, and address) were
erased, creating a numerical code for each case in the study, aiming to maintain the anonymity
of individuals, according to the determination of the research legislation in force in Brazil [19].
Statistical analyses
SPSS 21.0 (IBM) was used to perform the statistical analyses. The T-Student test was carried
out to compare the continuous age variable with DOT. Descriptive statistics were used to pres-
ent the characteristics of the participants and the occurrence of DOT. Comparisons were
made between patients who received and did not receive DOT regarding characteristics when
entering the surveillance system and at the closure, considering the possibility of cure and
death, through a homogeneity of proportions test based on Pearson’s chi-square statistic. The
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factors associated with DOT were analyzed by bivariate and multivariable models that esti-
mated the odds ratios by means of logistic regression with a 95% confidence interval. All vari-
ables were considered statistically significant (p-value of<0.05).
Ethics statement
This study complied with the guidelines of the Resolution 466/2012 of the Brazilian National
Health Council. The research project was approved by the Ethics and Research Committee of
the Federal University of Rio Grande do Sul (UFRGS) and by the Ethics Committee of the
Municipal Government of Porto Alegre, opinions 952907 and 939250, respectively. Since this
is a linkage study of national databases, patients needed to be identified for the linkage proce-
dure to succeed. This was informed in the research protocol to the ethics committee, which
approved the study, waiving the need for a term of consent.
Results
From 2009 to 2013, 8,813 TB cases were found in the SINAN-TB database. Of these, 75 were
duplicate cases, with double notification, which were excluded. Of the total, 2,419 cases had a
diagnosis of HIV at the time of TB notification, and therefore were considered coinfected.
Ten cases of HIV/AIDS patients that were not initially coinfected in SINAN-TB were found
in the national HIV/AIDS notification system. These patients were included in the study data-
base with the other people with both HIV and TB and were excluded from the statistical analy-
sis, as the fact that they did not present coinfection at the time of definition of DOT could
mean that they had not been listed for DOT. Thus, 2,419 cases of coinfection were found.
However, for 19 cases there was no information on the performance of DOT in SINAN-TB,
and these were excluded. The final sample was 2,400 cases of TB/HIV coinfection.
Of 2400 cases, DOT was performed in 17% (406). In relation to the year of registration, of
the 398 cases registered in 2009, 9.3% performed DOT. In 2013, of the 575 registers, 31.7% per-
formed DOT (<0.001). Considering the origin, the percentage of cases with DOT was from
9.5% to 26% (<0.001). Among whites the performance of DOT was 14.6%, and among non-
whites 20% (<0.001). The percentage of DOT varied according to schooling, being more fre-
quent in people with�7 years (p = 0.021) (Table 1).
Regarding the type of entry, a lower percentage of DOT was observed in new cases (12.7%),
and a higher percentage among cases of transference (35.7%) (p<0.001). DOT was received in
24.3% of the cases with alcohol abuse and in 14.4% of cases without alcohol abuse (p <0.001).
In 35.1% of the cases with mental health problems, DOT was received (p<0.001). DOT was
received in 17.4% of the cases of cure, 18.6% of the cases of default, 10.2% of the cases that
died, 20.7% of the cases that were transferred, and in 35.5% of the Multidrug-resistant TB
cases (p<0.001). The percentage of deaths in people who received DOT was 13% (54/406) and
the percentage of deaths in people who received conventional treatment was 24% (478/1994)
(Table 2).
The 1st sputum AFB test in DOT group was positive in 19% of cases, negative in 15.3%, and
not performed in 11%. In cases in which there was no DOT, this test was positive in 81%, nega-
tive in 84.7%, and not performed in 89% (p = 0.002). The 2nd sputum AFB test was positive in
19.5%, negative in 16.9% and not performed in 13.3% of the cases that underwent DOT. In the
group without DOT, this test was positive in 80.5% of the cases, negative in 83.1%, and not per-
formed in 86.7% (p = 0.003).
Alcohol abuse was associated in 24.3% of cases with DOT and in 75.7% of cases compared
to conventional treatment (p<0.001). Occurrence of mental disorders was associated in 35.1%
of the group that had DOT and in 64.9% of the group without DOT (p<0.001).
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The indication for DOT occurred in 51.5% of the group with DOT and 48.5% in the group
without DOT (p<0.001). In the group for which DOT was received, 17.4% of the cases evolved
to cure, 18.6% to default, 10.2% to death, 20.7% to transfer, and 35.5% to MDR-TB. In the
group for which DOT was not received, 82.6% evolved to cure, 81.4% to default, 89.8% to
death, 79.3% to transfer, and 64.5% to MDR-TB (p<0.001).
Chest X-ray (p = 0.279), diabetes (p = 0.508) and hospitalization (p = 0.231) did not present
a statistically significant difference within the groups studied.
Table 3 presents the factors associated with directly observed treatment. A positive associa-
tion was observed in the crude and adjusted models between year and DOT, being significant
for the years 2012 (p = 0.007) and 2013 (p<0.001). Considering the place of origin in the city,
Table 1. Sociodemographic characteristics and numbers receiving directly observed therapy among cases of TB/HIV coinfection in Porto Alegre, 2009–2013.
Characteristics Totalb Receiving DOTa p-value
Yes No
Reporting year <0.001�
2009 398 (16.6%) 37 (9.3%) 361 (90.7%)
2010 408 (17%) 44 (10.8%) 364 (89.2%)
2011 494 (20.6%) 48 (9.7%) 446 (90.3%)
2012 525 (21.9%) 95 (18.1%) 430 (81.9%)
2013 575 (24%) 182 (31.7%) 393 (68.3%)
DHAc < 0.001�
CEN 427 (17.8%) 111(26%) 316 (74%)
NHNI 158 (6.6%) 17 (10.8%) 141 (89.2%)
NEB 263 (11%) 26 (9.9%) 237 (90.1%)
LENO 376 (15.7%) 57 (15.2%) 319 (84.8%)
GCC 285 (11.9%) 40 (14%) 245 (86%)
SCS 168 (7%) 16 (9.5%) 152 (90.5%)
PLP 550 (22.9%) 112 (20.4%) 438 (79.6%)
RES 171 (7.1%) 27 (15.8%) 144 (84.2%)
Age 38±9.9 37.8±9.2 38±10 0.766���
Race/ethnicity <0.001��
White 1346 (56.3%) 196 (14.6%) 1.150 (85.4%)
Non-whited 1046 (43.7%) 209 (20%) 837 (80%)
Sex 0.457��
Male 1574 (65.6%) 273 (17.3%) 1.301 (82.7%)
Female 826 (34.4%) 133 (16.1%) 693 (83.9%)
Years of education completed 0.021�
�7 years 1536 (69.2%) 282 (18.4%) 1254 (81.6%)
8–11 years 625 (28.2%) 88 (14.1%) 537 (85.9%)
�12 years 59 (2.7%) 6 (10.2%) 53 (89.8%)
Total 2400 (100%) 406 (17%) 1994 (83%)
�Proportion homogeneity test based on Pearson’s chi-square statistic or ��Fischer’s exact test.
���T-student test for independent samples.
aDOT = Directly observed therapy.
bTotal data may differ due to the possibility of the non-response by participants.
cDistrict Health Authorities (DHA) = CEN: Centro, NEB: North/Baltazar Axis, LENO: East/Northeast, GCC: Gloria/Cruzeiro/Cristal, SCS: South/Center-South, PLP:
Partenon/Lomba do Pinheiro, RES: Restinga/South End, NHNI: Northwest/Humaitá/Navegantes/Ilhas.
dNon-white population is the sum of the colored population (black and brown), alongside Asians and indigenous people.
https://doi.org/10.1371/journal.pone.0222786.t001
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there was an association between the PLP and CEN locations and performance of DOT in the
crude and adjusted models. Patients at the CEN location had 2.29 (95% CI = 1.38–3.76) times
more chance of performing DOT, while PLP patients had 1.72 (95% CI = 1.04–2.85) times
more chance of performing DOT, when compared to SCS, the area with the lowest social
Table 2. Clinical and follow-up characteristics and the occurrence of directly observed therapy among cases of TB/HIV coinfection in Porto Alegre, 2009–2013.
Characteristics Totalb Receiving DOTa p-value
Yes No
Type of entry <0.001�
New case 1382 (57.6%) 175 (12.7%) 1207 (87.3%)
Relapse 347 (14.5%) 65 (18.7%) 282 (81.3%)
Readmission after default 615 (25.6%) 146 (23.7%) 469 (76.3%)
Transfer 56 (2.3%) 20 (35.7%) 36 (64.3%)
Chest X-ray 0.279�
Suspicion 2137 (89.2%) 366 (17.1%) 1771 (82.9%)
Normal 56 (2.3%) 9 (16.1%) 47 (83.9%)
Other pathology 29 (1.2%) 1 (3.4%) 28 (96.6%)
Not performed 173 (7.2%) 29 (16.8%) 144 (83.2%)
1st sputum AFB testc 0.002�
Positive 1414 (58.9%) 268 (19%) 1146 (81%)
Negative 687 (28.6%) 105 (15.3%) 582 (84.7%)
Not performed 299 (12.5%) 33 (11%) 266 (89%)
2nd sputum AFB testc 0.003�
Positive 1001 (41.7%) 195 (19.5%) 806 (80.5%)
Negative 661 (27.6%) 112 (16.9%) 549 (83.1%)
Not performed 736 (30.7%) 98 (13.3%) 638 (86.7%)
Indication for DOTa <0.001��
Yes 618 (25.8%) 318 (51.5%) 300 (48.5%)
No 1778 (74.2%) 87 (4.9%) 1691 (95.1%)
Alcohol abuse <0.001��
Yes 613 (25.6%) 149 (24.3%) 464 (75.7%)
No 1784 (74.4%) 257 (14.4%) 1527 (85.6%)
Diabetes 0.508��
Yes 66 (2.8%) 13 (19.7%) 53 (80.3%)
No 2330 (97.2%) 392 (16.8%) 1938 (83.2%)
Mental disorders <0.001��
Yes 97 (4.1%) 34 (35.1%) 63 (64.9%)
No 2297 (95.9%) 370 (16.1%) 1927 (83.9%)
Status at completion <0.001�
Cure 852 (35.7%) 148 (17.4%) 704 (82.6%)
Default 855 (35.8%) 159 (18.6%) 696 (81.4%)
Death 532 (22.2%) 54 (10.2%) 478 (89.8%)
Transfer 87 (3.6%) 18 (20.7%) 69 (79.3%)
MDR-TBd 62 (2.6%) 22 (35.5%) 40 (64.5%)
Total 2400 (100%) 406 (17%) 1994 (83%)
Homogeneity of proportions test based on Pearson’s chi-square statistic� or Fischer’s exact test��.
aDOT = Directly observed therapy,
btotal data may differ due to the possibility of the non-response by participants,
cAFB test = acid-fast bacilli test,
dMDR-TB = Multidrug-resistant TB.
https://doi.org/10.1371/journal.pone.0222786.t002
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Table 3. Factors associated with directly observed therapy in patients with TB/HIV coinfection in Porto Alegre,
2009–2013.







2010 1.16 (0.77–1.76) 1.16 (0.77–1.74) 0.489
2011 1.05 (0.69–1.57) 0.94 (0.62–1.42) 0.759
2012 1.95 (1.36–2.78) 1.64 (1.14–2.35) 0.007
2013 3.41 (2.45–4.73) 2.89 (2.07–4.05) <0.001
DHAd
CEN 2.73 (1.67–4.47) 2.28 (1.38–3.76) 0.001
NHNI 1.13 (0.59–2.16) 1.13 (0.60–2.13) 0.703
NEB 1.04 (0.57–1.88) 0.87 (0.48–1.59) 0.659
LENO 1.59 (0.94–1.69) 1.29 (0.76–2.19) 0.343
GCC 1.47 (0.85–2.55) 1.34 (0.78–2.31) 0.296
SCS 1.00 1.00
PLP 2.14 (1.30–3.51) 1.72 (1.04–2.85) 0.033
RES 1.66 (0.93–2.96) 1.72 (0.97–3.06) 0.064
Race/ethnicity
White 1.00 1.00
Non-white 1.37 (1.15–1.64) 1.29 (1.08–1.54) 0.006
Years of education completed
�7 years 1.81 (0.84–3.88) 1.52 (0.70–3.27) 0.289
8–11 years 1.39 (0.63–3.03) 1.29 (0.59–2.79) 0.524
�12 years 1.00 1.00
Type of entry
New case 1.00 1.00
Relapse 1.48 (1.14–1.92) 1.33 (1.03–1.72) 0.026
Readmission after default 1.88 (1.54–2.29) 1.48 (1.20–1.83) <0.001
Transfer 2.82 (1.93–4.12) 2.04 (1.40–2.98) <0.001
1st sputum AFB test
Positive 1.72 (1.22–2.41) 1.73 (1.24–2.42) 0.001
Negative 1.00 1.00
Not performed 1.39 (0.96–1.99) 1.48 (1.04–2.85) 0.032
Alcohol abuse
Yes 1.69 (1.41–2.02) 1.39 (1.16–1.67) <0.001
No 1.00 1.00
Mental disorders
Yes 2.18 (1.63–2.89) 1.83 (1.38–2.44) <0.001
No 1.00 1.00
aDOT = Directly observed therapy,
bunivariate models,
cmulti-variable model by the logistic regression method,
dDistrict Health Authorities (DHA) = CEN: Centro, NEB: North/Baltazar Axis, LENO: East/Northeast, GCC: Gloria/
Cruzeiro/Cristal, SCS: South/Center-South, PLP: Partenon/Lomba do Pinheiro, RES: Restinga/South End, NHNI:
Northwest/Humaitá/Navegantes/Ilhas.
https://doi.org/10.1371/journal.pone.0222786.t003
Factors associated with directly observed treatment in tuberculosis/HIV coinfection cases
PLOS ONE | https://doi.org/10.1371/journal.pone.0222786 October 2, 2019 8 / 14
vulnerability in the city. Non-white patients presented 1.29 (95% CI = 1.08–1.54) times more
chance of DOT when compared to whites. Years of education completed was not associated
with the outcome in the final model.
Considering the classification of type of entry in the surveillance system, the patients were
compared with the new cases (reference category). Patients classified as relapsing presented
1.33 (95% CI = 1.03–1.73) times more chance of performing DOT, patients classified as read-
missions after default had 1.48 (95% CI = 1.20–1.83) times more chance of DOT, and patients
with transfer presented 2.04 (95% CI = 1.40–2.98) times more chance of DOT. In relation to
the AFB test, patients with a positive result in the first sample presented 1.73 (95% CI = 1.24–
2.42) times more chance of performing DOT, and those without the examination had 1.48
(95% CI = 1.04–2.85) times more chance of DOT. Patients with alcohol abuse presented 39%
(OR = 1.39; 95% CI = 1.16–1.67) more DOT when compared to patients without alcohol
abuse. Patients with mental disorders presented 83% more DOT (OR = 1.83; 95% CI = 1.38–
2.44) when compared to patients without mental disorders.
Discussion
DOT is a strategy advocated by the WHO for coping with tuberculosis, particularly in cases of
drug resistance and coinfection with HIV [20]. Comparing health outcomes in patients who
perform and do not perform DOT makes it possible to highlight the impact of this strategy. In
2015, a systematic review with 11 clinical trials including 5,662 participants showed that there
were virtually no differences in cure rates when comparing patients with DOT to other meth-
ods. In 2018, a new systematic review identified 7,729 articles, of which 129 evidenced that
DOT improves adherence compared to other treatment methods [21]. TB/HIV coinfection is
a double burden of diseases, with high incidence and mortality rates in Brazil, cases of TB/HIV
coinfection have been prioritized for DOT, due to greater vulnerability to treatment abandon-
ment, MDR-TB, and mortality [11,22,23].
Between 2007 and 2011, a study carried out in the same scenario of this research found that
among the new cases of TB, 10.7% received DOT, and among all TB cases, the percentage of
DOT was 14.7% [22]. In Porto Alegre, in 2016, 15.3% of the cases of pulmonary TB performed
DOT. In the state of Rio Grande do Sul (RS), whose capital is Porto Alegre, this figure reached
17.2%, and in Brazil, 36.3% [4]. In countries where the burden of tuberculosis is immense,
despite the increase in the number of cases, there is evidence of an increase in DOT, with a
positive impact on the scenario of illness [24,25].
Between 2009 and 2013, there was an increase in the number of notifications of TB/HIV
coinfection and in the performance of DOT. While the proportion of coinfection increased by
approximately 8% over 5 years, the proportion of subjects performing DOT increased from
9.3% to 31.7% in the same period. In this sense, greater odds of performing DOT were
observed in the last two years of the cohort, i.e., 2012 (p = 0.007) and 2013 (p<0.001). This
finding may be related to the decentralization policy of tuberculosis care, instituted in 2011. In
this policy, primary care began performing contact evaluation and referring patients with diag-
nostic difficulties and people living with HIV to the Reference Centers in Tuberculosis
(CRTB), as well as receiving users referred from the CRTB or other specialized services for the
performance of shared DOT [18,26]. Thus, even if coinfection cases refer to CRTB care, this
care is not exclusive to the referral service but is recommended to be shared with Primary
Care. This coping strategy aims to reduce the high rates of TB that exist in Brazil and improve
adherence to antiretroviral therapy. Recently, a study in Ethiopia also recommended decen-
tralizing treatment as a strategy to increase adherence [25].
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Other factors may have contributed to the expansion of DOT. Although in Porto Alegre, it
tends to be lower than in the state of Rio Grande do Sul (42.08%), and Brazil (56.37%), between
2009 and 2013, the Family Health Strategy (FHS) coverage increased from 22.4% to 31.2%
[27]. Through the implementation of FHS, there are more health professionals throughout the
city of Porto Alegre.
Moreover, because of the high incidence of TB/HIV coinfection in Porto Alegre, the state
capital in Brazil with the highest incidence of TB and HIV, the primary care system has
deemed it opportune to discuss the decentralization of HIV/AIDS care and carry out the pro-
posal for decentralization of tuberculosis testing and treatment [28].
The logistic regression model showed a 2.28 fold higher chance of performing DOT for
patients at the CEN site. The high vulnerability index of the district and the presence of the
population in situations of homelessness are highlighted. The region also presents high rates of
violence, mortality due to external causes, high numbers of families living in extreme poverty,
and population over crowding in large favelas [18]. All these factors increase the vulnerability
of the individuals in this situation [29,30]. Notwithstanding, the district has a health center
that is historically considered one of the pioneers in tuberculosis treatment [18]. Sex and age
were not associated with the outcome, as in other studies that point out that these are not deci-
sive factors for the performance of DOT [31–33]. In terms of sociodemographic variables, data
on race and schooling show the vulnerability associated with DOT. Although the highest pro-
portion of cases of coinfection involved white individuals, there was a greater indication of
DOT for non-whites. The adjusted regression model showed that, despite the differences in
proportion, non-white patients presented a 29% greater chance of DOT when compared to
whites. A recent study conducted in the same scenario showed that the need for hospitalization
for TB treatment is more frequent in non-white patients living in poverty [34]. In our study,
schooling was used as a proxy for the economic situation, and, although schooling was not
associated with DOT, the lower the schooling, the greater the percentage of DOT, a trend
already observed in other studies [33,35].
Reinforcing the vulnerability pointed out by other authors that associate the occurrence of
alcohol abuse and mental illness with the difficulty of adherence to treatments [36,37], our
study, observed that patients with alcohol abuse presented a 39% higher level of DOT perfor-
mance than those without a history of abusive use. Moreover, those with mental disorders pre-
sented a 83% greater performance of DOT.
Considering the admission classification in SINAN, patients with readmission after aban-
donment presented 1.48 times more chance of performing DOT when compared to new cases.
Relapse cases presented 1.33 times more chance of DOT, and transfer cases presented 2.04
times more chance of DOT. Treatment abandonment is one of the main challenges in address-
ing TB/HIV coinfection. The main consequences are the development of MDR-TB, increased
hospitalizations, occurrence of mortality, and higher treatment costs [20,38,39].
Regarding the AFB sputum test for the diagnosis of TB, the result of the positive bacillo-
scopy was more frequent in DOT group in the 1st sputum collection. The maintenance of the
tuberculosis transmission chain is related to the bacilliferous cases of the disease [40], evidenc-
ing the need for intervention in these cases. It is possible that the finding of 1.73 times greater
chance of performing DOT in patients with positive AFB in the 1st test is related to the great
concern among health professionals of the transmissibility of TB [40]. It is also worth noting
that sputum smear microscopy is the most widely used method for the diagnosis of the disease,
and, when correctly performed, allows the detection of 60–80% of cases [40].
The difference of proportions found in the indication of DOT was already expected. Never-
theless, it is noted that 48.5% of the cases indicated did not perform DOT, while 4.9% of the
cases that had no indication did perform DOT. These two groups require further investigation
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regarding their follow-up and outcomes as these findings are possibly related to the difficulties
of the health services in offering DOT to those who are indicated at the start of follow-up
[41,42].
Regarding the closure situation, although the highest percentage of cure was in the group
without DOT, the highest proportion of MDR-TB was found in the group without DOT
(64.5% versus 35.5%), a higher proportion of abandonment (81.4%) in the group without
DOT [43–45], and among those who died 89.8% received conventional treatment and e 10.2%
received DOT, demonstrating the effectiveness of this follow-up, as already indicated in other
studies [46,47].
The main limitation of this study is the design adopted. In the retrospective cohort studies,
the data were already recorded before the study. Despite this, it should be noted that in this
study, the data used came from the national health information systems, in which compulsory
notification phenomena are registered (tuberculosis & AIDS and death) and, therefore, have
high reliability.
Conclusion
The study evidenced an increase in DOT over the five years of the cohort. Higher odds of per-
forming DOT were observed in the CEN district, in the cases with low schooling, among non-
whites, in situations of relapse and readmission after abandonment, in cases with a positive
first sputum sample, and in those that presented alcohol abuse and mental disorders as comor-
bidities, thereby indicating the context of vulnerability of coinfection. The association of these
variables with the performance of DOT may indicate a greater ability of health professionals to
identify subjects with a potential risk of treatment abandonment.
The study showed that, among patients who died, most had not received DOT, thus sug-
gesting a protective effect. Therefore, as the reduction in mortality related to tuberculosis and
HIV/AIDS is one of the major concerns when addressing coinfection, DOT has emerged as an
effective strategy and should be expanded within health teams.
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org/10.5123/s1679-49742018000300015 PMID: 30365701
14. Rossetto M, Brand EM, Rodrigues RM, Serrant L, Teixeira LB. Factors associated with hospitalization
and death among TB/HIV coinfected persons in Porto Alegre, Brazil. PLoS ONE. 2019; 14(1):
e0209174. https://doi.org/10.1371/journal PMID: 30601842
15. Rothman KJ, Greeland S, Lash TL. Modern Epidemiology. 3rd ed. Porto Alegre: Artmed; 2011.
16. Brasil. Notification of Injury Information System. 2018. http://portalsinan.saude.gov.br/. Accessed 25
Jun 2018.
17. Brasil. Mortality Information System. 2018. http://www2.datasus.gov.br/DATASUS/index.php?area=
060701. Accessed 25 Jun 2018.
18. Porto Alegre. Municipal Health Plan 2018 to 2021. Porto Alegre: City Hall of Porto Alegre; 2017.
19. Brazil. Resolution n˚ 466 of December 12, 2012. Brası́lia: Ministry of Health; 2012. http://bvsms.saude.
gov.br/bvs/saudelegis/cns/2013/res0466_12_12_2012.html. Accessed 13 Mar 2018.
20. World Health Organization. The End TB Strategy. Geneva, Switzerland: 2017. https://www.who.int/tb/
End_TB_brochure.pdf. Accessed 04 Jul 2018.
21. Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, Nahid P. Adherence interventions and
outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational
Factors associated with directly observed treatment in tuberculosis/HIV coinfection cases
PLOS ONE | https://doi.org/10.1371/journal.pone.0222786 October 2, 2019 12 / 14
studies. PLoS Med. 2018; 15(7):e1002595. https://doi.org/10.1371/journal.pmed.1002595 PMID:
29969463
22. World Health Organization. Global tuberculosis control 2011. Geneva, Switzerland: Dec. 2011.
23. Peruhype RC, Acosta LMW, Ruffino-Netto A, Oliveira MMC, Palha PF. Distribuição da tuberculose
em Porto Alegre: análise da magnitude e coinfecção tuberculose-HIV. Rev esc enferm USP. 2014;
48(6):1035–43.
24. Anand T, Sharma N, Chandra S, Ingle GK, Grover S. Decadal impact of Directly Observed Treatment
Short course program on age and gender among New Infectious Tuberculosis cases in Delhi. Indian J
Tuberculosis. 2017; 64(4): 291–295.
25. Woimo TT, Yimer WK, Bati T, Gesesew HA. The prevalence and factors associated for anti-tuberculo-
sis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in
South Ethiopia: a cross-sectional study. BMC Public Health. 2017; 17(269):1–10.
26. Rio Grande do Sul. State Department of Health. State Center for Health Surveillance. Epidemiological
Surveillance Division. The State Plan for Tuberculosis Control.Porto Alegre;2010. http://www.saude.rs.
gov.br/upload/1339784445_Plano%20Estadual%20de%20Controle%20da%20Tuberculose.pdf.
Acessed 11 Jun 2017.
27. Brazil. Ministry of Health. Basic Attention Department. History of Family Health Coverage. Brazil; 2017.
http://dab.saude.gov.br/portaldab/historico_cobertura_sf.php. Acessed 02 Jul 2017
28. Zambenedetti G, Silva RAN. Decentralization of attention in HIV-AIDS to basic care: tensions and
potentialities. Physis: Rev Saud Colet; 26(3):785–806.
29. Porto Alegre. Municipal Health Department of Porto Alegre. General Coordination of Health Surveil-
lance. Communicable Disease Surveillance Team. Epidemiological Bulletin 59. Porto Alegre; 2015.
30. Riley LW, Ko AI, Unger A, Reis MG. Slum health: diseases of neglected populations. BMC Int Health
Hum Rights. 2007; 7:2. https://doi.org/10.1186/1472-698X-7-2 PMID: 17343758
31. Snyder RE, Marlow MA, Phuphanich ME, Riley LW, Maciel EL. Risk factors for differential outcome fol-
lowing directly observed treatment (DOT) of slum and non-slum tuberculosis patients: a retrospective
cohort study. BMC Infect Dis. 2016; 16:494. https://doi.org/10.1186/s12879-016-1835-1 PMID:
27647383
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